Skip to main content

Mast Cells: Bridging Host-Microorganism Interactions

97kviews
Editorial31 January 2022
Editorial: Mast Cells: Bridging Host-Microorganism Interactions

Mast cells (MCs) evolved as part of the innate immune system more than 500 million years ago to respond to different signals from microorganisms that establish different interactions with the host, ranging from mutualistic to parasitic. This article collection illustrates how MCs influence the immune system's relationship with different microorganisms and how these MC responses modulate subsequent host-microorganism interplay.

In a comprehensive overview, Jiménez et al. describe the MC’s biology and main functions with a particular focus on the up-to-date interaction with microorganisms, ranging from viruses to parasites. They discuss the importance of MC mechanisms to induce protection against infections and they also illustrate the damage associated with exacerbated MC activation during different infectious diseases.

Yu et al. discuss the importance of MC activation during fungal infections. They review experimental evidence of the MC’s role during infection with the fungi Candida albicans, Aspergillus fumigatus, and Sporothrix schenkii.

Because of their strategic location, MCs are sentinels at the epithelial interface and are first responders in host-microbiome interactions. MCs primarily express their interaction through several innate immune receptors, such as Toll-Like Receptors (TLRs). As Soria-Castro, et al. describe during the infection with Listeria monocytogenes, MCs response is mediated through TLR2 activation. However, they can also respond when TLR2 is blocked, using other innate immune receptors.

Draberova et al. describe alternate pathways of MCs activation during infection focusing on Gram-positive bacterial exotoxins that promote cholesterol-dependent cellular lysis. At low concentrations, these exotoxins cause pore formation in the MCs membrane leading to the activation of different cell signaling molecules that induce MC degranulation and production of several inflammatory mediators. Interestingly, other molecules that can modify the MCs membrane integrity can mimic this activation pathway.

However, the significance of MCs in host defense is more evident when we see MCs also modulate the acquired immune system. Palma et al. illustrate how MCs modulate B-cell responses. Their review describes the critical impacts of MCs on B cells using information from both clinical and laboratory studies. They also discuss the implications of these findings on host responses to infections.

Antibody responses can modulate MCs reaction to microorganisms, which is illustrated by Mamontov et al. during influenza virus infection, turning the capacity of MCs to recognize viruses into a damaging response. This study elegantly shows that virus-specific non-neutralizing antibodies can interact with MCs upon infection with the avian influenza virus. It is suggested that this antibody-mediated MC response, which includes significant histamine release, could potentially cause side effects when vaccinated subjects are infected with the influenza virus.

A second level of MC interactions with the adaptive immune response is evident during T cell activation following viral infections. Employing MCs deficient mice, Hackler et al. reveal the critical role played by MCs in promoting adequate dendritic cell activation and the induction of specific T CD8+ responses that limit the infection of lymphocytic choriomeningitis virus.

The ability of MCs to participate in the control of bacterial infections can be exploited by employing distinct polypeptides that target specific molecules on MCs. For example, Amponnawarat et al. show that murepavadin, a lipopolysaccharide transport protein D (LptD)- binding host defense peptidomimetic antimicrobial peptide that targets multi-drug resistant Pseudomona aureginosa, can activate MCs in vitro through Mas-Related G Protein-Coupled Receptor member X2 (MRGPRX2), inducing degranulation and cytokine production. Moreover, in vivo they revealed that murepavadin increases vascular permeability in mice.

Finally, Yeh et al. reveal that the MC’s interactions with microorganisms can be a bidirectional response, where interactions with microbiota impact MC distribution in the lungs. They showed that mice captured in the wild exhibited a remarkable presence of MCs in lung parenchyma compared to specific pathogen-free mice from the conventional laboratory. Remarkably, when laboratory mice were bred in conditions that mimicked the wild environment, they exhibited increased MCs in the lungs.

In conclusion, this research topic updates the current state of knowledge regarding MC crosstalk with mutualistic and parasitic microorganisms and how this interaction impacts innate and adaptive immune response modulating host homeostasis. The MC’s role clearly depends on the nature of its interactions with specific microorganisms, as these interactions can promote either protection or damage to the host. Purposeful modulation of some of these interactions can reveal new therapeutic targets and novel strategies to combat infectious diseases.

2,426 views

Mast Cell Modulation of B Cell Responses: An Under-Appreciated Partnership in Host Defence
Mast cells are well known to be activated via cross-linking of immunoglobulins bound to surface receptors. They are also recognized as key initiators and regulators of both innate and adaptive immune responses against pathogens, especially in the skin and mucosal surfaces. Substantial attention has been given to the role of mast cells in regulating T cell function either directly or indirectly, through actions on dendritic. In contrast, the ability of mast cells to modify B cell responses has been much less well examined. Several lines of evidence suggest that mast cells can modify B cell development and activities substantially. Mast cells co-localize with B cells in many tissue settings and produce substantial amounts of cytokines, such as IL-6, with profound impacts on B cell development, class-switch recombination events and subsequent antibody production. Mast cells have also been suggested to modify the development and function of regulatory B cells. In this review, we bring together the critical current, clinical and laboratory information on the impact of mast cells and their mediators on B cell development and function and consider the implications of these findings on the host response to infection.

14,044 views

39 citations

6,977 views

10 citations

Mast cells (MCs) are strategically located in tissues close to the external environment, being one of the first immune cells to interact with invading pathogens. They are long living effector cells equipped with different receptors that allow microbial recognition. Once activated, MCs release numerous biologically active mediators in the site of pathogen contact, which induce vascular endothelium modification, inflammation development and extracellular matrix remodeling. Efficient and direct antimicrobial mechanisms of MCs involve phagocytosis with oxidative and non-oxidative microbial destruction, extracellular trap formation, and the release of antimicrobial substances. MCs also contribute to host defense through the attraction and activation of phagocytic and inflammatory cells, shaping the innate and adaptive immune responses. However, as part of their response to pathogens and under an impaired, sustained or systemic activation, MCs may contribute to tissue damage. This review will focus on the current knowledge about direct and indirect contribution of MCs to pathogen clearance. Antimicrobial mechanisms of MCs are addressed with special attention to signaling pathways involved and molecular weapon implicated. The role of MCs in a dysregulated host response that can increase morbidity and mortality is also reviewed and discussed, highlighting the complexity of MCs biology in the context of host-pathogen interactions.

17,538 views

80 citations

ORIGINAL RESEARCH
14 June 2021
TLR2 Regulates Mast Cell IL-6 and IL-13 Production During Listeria monocytogenes Infection
Rodolfo Soria-Castro, 12 more and Rommel Chacón-Salinas

7,001 views

18 citations

ORIGINAL RESEARCH
14 June 2021
Mast Cells Modulate Antigen-Specific CD8+ T Cell Activation During LCMV Infection
Yana Hackler, 3 more and Melba Muñoz

5,378 views

18 citations

Mast cells (MCs) have been considered as the core effector cells of allergic diseases. However, there are some evidence suggesting that MCs are involved in the mechanisms of fungal infection. MCs are mostly located in the border between host and environment and thus may have easy contact with the external environmental pathogens. . These cells express receptors which can recognize pathogen-associated molecular patterns such as Toll-like receptors (TLR2/4) and C-type Lectins receptors (Dectin-1/2). Currently, more and more data indicate that MCs can be interacted with some fungi (Candida albicans, Aspergillus fumigatus and Sporothrix schenckii). It is demonstrated that MCs can enhance immunity through triggered degranulation, secretion of cytokines and chemokines, neutrophil recruitment, or provision of extracellular DNA traps in response to stimulation by fungi. In contrast, the involvement of MCs in some immune response may lead to more severe symptoms, such as intestinal barrier function loss, development of allergic bronchial pulmonary aspergillosis and increased area of inflammatory in S. schenckii infection. This suggests that MCs and their relevant signaling pathways are potential treatment regimens to prevent the clinically unwanted consequences. However, it is not yet possible to make definitive statements about the role of MCs during fungal infection and/or pathomechanisms of fungal diseases. In our article, we aim to review the function of MCs in fungal infections from molecular mechanism to signaling pathways, and illustrate the role of MCs in some common host-fungi interactions.

15,454 views

21 citations